University Hospitals Bristol NHS Foundation Trust (UH Bristol) in partnership with the University of Bristol has been awarded more than £20 million over five years by the National Institute for Health Research (NIHR) to fund cutting-edge research.
New research led by Imperial College London and co-authored by the University of Bristol, has revealed that aerial robotics could provide wide-ranging benefits to the safety, sustainability and scale of construction.
Relationships between GPs and patients are changing. It is becoming more difficult for patients to see their preferred GP. In a study by researchers from the University of Bristol's Centre for Academic Primary Care, patients reported that, regardless of whether they were able to see the same GP or not, what they most wanted is to be trusted and respected by their GP.
Ultra-thin, super-absorbent and extraordinarily designed to detract attention, the wings of moths could hold the key for developing technological solutions to survive in a noisy world.
A study has shown that a dangerous game of ‘brinkmanship’ between rival genes in mammals could help explain why many fertilised eggs don’t result in a new life.
Have you ever looked for something in a teenager's bedroom? Tough, isn't it? Everyday experience tells us that when the background is cluttered, it's harder to find an object. But how should we define "complexity" and can we apply the same concepts to other animals?
Repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir and interferon - to treat COVID-19 appear to have little or no effect on patients hospitalised for the disease, in terms of overall mortality, initiation of ventilation and duration of hospital stay. The interim findings from the WHO Solidarity trial, published in the New England Journal of Medicine (NEJM), followed 11,266 adults at 405 hospitals in 30 countries.
A team of scientists and engineers, including three academics from Bristol, has won a prestigious award for field research on Ascension Island using lightweight drones.
The AstraZeneca Oxford COVID-19 vaccine (ChAdOx1 nCoV-19 and also known as AZD1222) now undergoing Phase III clinical trials, has already undergone rigorous testing to ensure the highest standards of quality and safety. Now a team at Bristol University has used recently developed techniques to further validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford team. This novel analysis provides even greater clarity and detail about how the vaccine successfully provokes a strong immune response.
In their notorious battles with snakes, dwarf mongooses are more likely to help attack the enemy if they are closely bonded to the individual raising the alarm, reports new experimental research from scientists at the University of Bristol.
